Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis.

ABSTRACT:

Objective

The number of reported cases of Campylobacter enteritis (CE) remains on a high level in many parts of the world. The aim of this study was to analyze the health care utilizations and direct and indirect costs of CE and sequelae of patients insured by a large health insurance with 26 million members in Germany.

Methods

Claims data of insurants with at least one CE diagnosis in 2017 (n = 13,150) were provided, of which 9,945 were included in the analysis of health care utilizations and costs. If medical services were not diagnosis-linked, CE-associated costs were estimated in comparison to up to three healthy controls per CE patient. Indirect costs were calculated by multiplying the work incapacities by the average labor costs. Total costs of CE in Germany were extra

SUBMITTER: Schorling E 

PROVIDER: S-EPMC10075411 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature